These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30989829)

  • 1. Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes.
    MacIsaac RJ; Farag M; Obeyesekere V; Clarke M; Boston R; Ward GM; Jerums G; Ekinci EI
    J Diabetes Investig; 2019 Nov; 10(6):1537-1542. PubMed ID: 30989829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
    Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
    Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
    J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
    Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
    Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
    Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
    Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.
    Chang LH; Hwu CM; Chu CH; Lin YC; Huang CC; You JY; Chen HS; Lin LY
    J Endocrinol Invest; 2021 Dec; 44(12):2609-2619. PubMed ID: 33834419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
    Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
    PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
    Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
    Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
    Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
    J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
    Gohda T; Niewczas MA; Ficociello LH; Walker WH; Skupien J; Rosetti F; Cullere X; Johnson AC; Crabtree G; Smiles AM; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):516-24. PubMed ID: 22266664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.
    Bhatraju PK; Zelnick LR; Shlipak M; Katz R; Kestenbaum B
    J Am Soc Nephrol; 2018 Nov; 29(11):2713-2721. PubMed ID: 30287518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
    Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
    Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes.
    Bjornstad P; Cherney DZ; Snell-Bergeon JK; Pyle L; Rewers M; Johnson RJ; Maahs DM
    Nephrol Dial Transplant; 2015 Oct; 30(10):1706-11. PubMed ID: 26050268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.
    Saulnier PJ; Gand E; Velho G; Mohammedi K; Zaoui P; Fraty M; Halimi JM; Roussel R; Ragot S; Hadjadj S;
    Diabetes Care; 2017 Mar; 40(3):367-374. PubMed ID: 27998909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and higher HbA1c levels are independently associated with adverse renal outcomes in inpatients following multiple hospital admissions.
    Torkamani N; Churilov L; Robbins R; Jerums G; Beik V; Radcliffe N; Patterson S; Bellomo R; Burns J; Hart GK; Lam Q; Power DA; MacIsaac RJ; Johnson DF; Zajac J; Ekinci EI
    J Diabetes Complications; 2020 Jan; 34(1):107465. PubMed ID: 31735639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.